home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
press releases
11/20/2024
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
read more
11/07/2024
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
read more
09/11/2024
PainReform Ltd. Confirms Sutures Compatibilityin Human Clinical Trials for PRF-110
read more
09/10/2024
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
read more
08/21/2024
PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures
read more
08/20/2024
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
read more
